Objective: To explore the clinical feasibility and safety of modified endoscopic mucosal resection for rectal neuroendocrine tumors (R-NETs). Methods: Seventy cases of R-NETs treated with endoscopic mucosal resection in our hospital between April 2022 and March 2024 were selected and divided into the control group and the observation group using the mean score method, each with 35 cases. In the control group, traditional endoscopic mucosal resection (EMR) was performed, and in the observation group, modified EMR (endoscopic mucosal resection with ligation apparatus [EMR-L]) was performed. The operation time, hospitalization time, operation cost, and related complication rate of the two groups of patients were compared. Results: The operation time (20.36 ± 1.46 min) and hospital stay (3.37 ± 0.51 d) of patients in the observation group were shorter than those of the control group (31.44 ± 2.65 min and 4.73 ± 0.49 d). The cost of the operation in the observation group (7,695.85 ± 1,521.42 yuan) was lower than that of the control group (8,418.62 ± 1219.30 yuan), and the difference was statistically significant (P < 0.05). The total incidence of postoperative related complications in the observation group was observed to be 11.42%, which was significantly lower than that of 31.42% in the control group, and the difference was statistically significant (P < 0.05). Conclusion: The application of modified EMR in R-NETs is remarkable, which can not only effectively shorten the operation time and hospital stay, but also further reduce the risk of related complications, and indirectly save a large amount of hospital costs; thus, it is recommended to be promoted and applied clinically.
Luo P, Liu A, Yi C, et al., 2025, Analysis of the Effect of Ultrasonic Endoscopy Combined with Modified Endoscopic Mucosal Resection in the Treatment of Rectal Neuroendocrine Tumors. Chongqing Medical Journal, OnlineFirst, 1–10.
Zhang L, Liu M, Li Q, et al., 2024, Modified Endoscopic Mucosal Resection in Rectal Neuroendocrine Tumors. Journal of Gastroenterology and Hepatology, 33(02): 218–222.
Gao X, 2023, Randomized Controlled Clinical Study of Modified Transparent Cap-Assisted Endoscopic Submucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Rectal Neuroendocrine Tumors Less than or Equal to 10 mm, dissertation, Southern Medical University.
Sun H, Han Z, Pei GY, et al., 2023, Application and Prognostic Analysis of Modified Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD) in Rectal Neuroendocrine Tumors. Modern Digestive and Interventional Diagnosis and Treatment, 28(03): 358–363.
Chen G, Sun C, Chai HN, et al., 2022, Endoscopic Mucosal Resection by Lancing Method in Rectal Neuroendocrine Tumors. Journal of Practical Clinical Medicine, 26(18): 21–25.
Chen S, Du S, 2020, Modified Method of Endoscopic Mucosal Resection in the Treatment of Rectal Neuroendocrine Tumors. Journal of China-Japan Friendship Hospital, 34(03): 173–175.
Tang QY, Wang F, Liu Y, et al., 2022, Difficulties and Hotspots in the Diagnosis and Treatment of Neuroendocrine Tumors of the Digestive System. Chinese Medical Journal, 102(14): 977–981.
Gastrointestinal Hormones and Neuroendocrine Tumors Group of the Gastroenterological Diseases Branch of the Chinese Medical Association, 2021, Expert Consensus on the Diagnosis and Treatment of Gastrointestinal and Pancreatic Neuroendocrine Tumors (2020 Guangzhou). Chinese Journal of Gastroenterology, 41(2): 76–87.
Maione F, Chini A, Milone M, et al., 2021, Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs). Diagnostics (Basel), 11(5): 771.
Wang XY, Chai NL, Linghu EQ, et al., 2020, Efficacy and Safety of Hybrid Endoscopic Submucosal Dissection Compared with Endoscopic Submucosal Dissection for Rectal Neuroendocrine Tumors and Risk Factors Associated with Incomplete Endoscopic Resection. Ann Transl Med, 8(6): 368.
Liu X, Tou B, 2021, Endoscopic Diagnosis and Treatment of Gastrointestinal Neuroendocrine Tumors. Chinese Journal of Gastrointestinal Surgery, 24(10): 854–860.
Xu TM, Cheng XY, Yan PG, et al., 2021, Clinical and Pathological Characterization of Rectal Neuroendocrine Tumors. Chinese Journal of Internal Medicine, 60(10): 886–890.